Skip to content

Why Organo Gold’s Coffee is Essential for People Desirous of a Healthy Life

Although many Americans consume coffee more than once in a day, most of them have not researched about the health benefits associated with the beverage. This will come as good news for coffee lovers: the beverage keeps common diseases at bay. Consequently, improving the quality of life and reducing the chances of dying from diseases such as heart disease, cancer, stroke, diabetes and urological diseases.

Research backs the claim that coffee can lengthen the lives of those who partake in it. In fact, Annals of Internal Medicine, a revered medical journal published by the American College of Physicians recently carried two studies to this effect. The two studies, one done in the U.S and the other in Europe, were concluded on the same note: coffee is crucial for people wishing to lead healthy lifestyles.
The European and the American studies were done almost in a similar manner. The American research investigated 185 thousand Americans over a period of 16 years. The type of people under the investigation were both coffee drinkers and non-coffee drinkers. Of course, researchers were keen to identify any factors that could compromise the study. For example, they separated non-smokers from smokers. Those under investigation reported their coffee drinking habits every five years. The European research was done just like the American study only that it focused on a larger group of people—over 520 thousand from over ten countries. Researchers concluded that regardless of race, those who drink coffee regularly lived longer than those who drank less or avoided the beverage.
About Organo Gold
Organo Gold is an American company which sells premium coffee with a slew of health benefits owing to the inclusion of Ganoderma lucidum from the lingzhi mushroom. The company retails its products through a multi-level marketing distribution network. Organo Gold’s products are available in over 50 countries.

Follow Organo Gold on Facebook for current updates.

Comments are closed.

Leave a Reply

Your email address will not be published. Required fields are marked *